Pharmaceutical manufacturing currently anchors the market, accounting for 62% of global revenue. The solvent remains a linchpin in active pharmaceutical ingredient synthesis and high-performance liquid chromatography. As global laboratories and biotech firms push for greater precision in drug discovery and vaccine production, the reliance on high-purity acetonitrile continues to scale accordingly.
In section Releases
Global Acetonitrile Market Poised for Growth as Industrial Demand Rises
The global market for acetonitrile is set to climb to 567.5 million USD by 2035, driven by the expanding pharmaceutical sector and the emergence of lithium-ion battery production. Industry analysts project a steady compound annual growth rate of 5.5% over the next decade as high-purity solvent requirements intensify.
Beyond medicine, the energy transition is reshaping production priorities. Manufacturers are increasingly integrating acetonitrile into electrolyte formulations for lithium-ion batteries, citing its chemical stability and low moisture content as critical advantages. While the sector faces supply complexities—often tied to its status as a by-product of acrylonitrile production—major players like INEOS AG are pivoting toward sustainable, bio-based manufacturing to mitigate environmental impact and meet stringent global regulations.
Comments (0)
No comments yet. Be the first!